In-house advantage FabGennix develops and characterizes antibodies in-house, enabling faster turnaround times and cost efficiency. This presents a sales opportunity to position compatible lab tools, reagents, and custom development services as a time-saving and cost-effective alternative to resellers for research institutions seeking rapid project progression.

Broad catalog With over 6,000 validated antibodies and coverage across neuroscience, cell biology, cancer biology, signal transduction, and metabolic disease, there is potential to upsell catalog products to ongoing studies and provide bundled solutions combining existing antibodies with protein reagents and validation data.

Custom development FabGennix offers custom antibody development and characterization services. This opens opportunities to engage with labs pursuing niche targets or need tailored affinity, specificity, or format, expanding the addressable market beyond catalog sales.

Research tool ecosystem Beyond antibodies, the company supports PDE inhibitor screening, protein purification, and molecular biology applications. A sales angle includes offering integrated toolkits or service packages that streamline end-to-end project workflows for disease biology and translational research teams.

Size and growth potential Small team (2-10 employees) with revenue in the lower-mid range signals agility but also a potential constraint for scale. Sales conversations can emphasize scalable reagent supply, predictable lead times, and strategic partnerships to accelerate market penetration against larger competitors.